{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:03:17Z","timestamp":1777867397184,"version":"3.51.4"},"reference-count":69,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.trsl.2008.11.003","type":"journal-article","created":{"date-parts":[[2008,12,5]],"date-time":"2008-12-05T10:54:25Z","timestamp":1228474465000},"page":"33-43","source":"Crossref","is-referenced-by-count":16,"title":["Enoxaparin-metformin and enoxaparin alone may safely reduce pregnancy loss"],"prefix":"10.1016","volume":"153","author":[{"given":"Ganga","family":"Ramidi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naseer","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles J.","family":"Glueck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naila","family":"Goldenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2008.11.003_bib1","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0026-0495(99)90250-0","article-title":"Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome","volume":"48","author":"Glueck","year":"1999","journal-title":"Metabolism"},{"key":"10.1016\/j.trsl.2008.11.003_bib2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0015-0282(00)01666-6","article-title":"Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study","volume":"75","author":"Glueck","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.trsl.2008.11.003_bib3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.metabol.2005.09.008","article-title":"Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome","volume":"55","author":"Glueck","year":"2006","journal-title":"Metabolism"},{"key":"10.1016\/j.trsl.2008.11.003_bib4","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/107602960401000404","article-title":"Pregnancy loss, polycystic ovary syndrome, thrombophilia, hypofibrinolysis, enoxaparin, metformin","volume":"10","author":"Glueck","year":"2004","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.trsl.2008.11.003_bib5","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1210\/jc.87.2.524","article-title":"Effects of metformin on early pregnancy loss in the polycystic ovary syndrome","volume":"87","author":"Jakubowicz","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.trsl.2008.11.003_bib6","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.fertnstert.2007.03.036","article-title":"Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome","volume":"89","author":"Glueck","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.trsl.2008.11.003_bib7","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/humrep\/17.11.2858","article-title":"Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin","volume":"17","author":"Glueck","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.trsl.2008.11.003_bib8","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1464-5491.2004.01251.x","article-title":"Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome","volume":"21","author":"Glueck","year":"2004","journal-title":"Diabet Med"},{"key":"10.1016\/j.trsl.2008.11.003_bib9","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1080\/09513590601010508","article-title":"Metformin reduces abortion in pregnant women with polycystic ovary syndrome","volume":"22","author":"Khattab","year":"2006","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.trsl.2008.11.003_bib10","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.fertnstert.2007.06.079","article-title":"Relationship between abnormal glucose tolerance test and history of previous recurrent miscarriages, and beneficial effect of metformin in these patients: a prospective clinical study","volume":"90","author":"Zolghadri","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.trsl.2008.11.003_bib11","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0026-0495(94)90209-7","article-title":"Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy","volume":"43","author":"Velazquez","year":"1994","journal-title":"Metabolism"},{"key":"10.1016\/j.trsl.2008.11.003_bib12","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0026-0495(97)90066-4","article-title":"Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome","volume":"46","author":"Velazquez","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/j.trsl.2008.11.003_bib13","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0015-0282(01)02971-5","article-title":"Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage","volume":"77","author":"Sarig","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.trsl.2008.11.003_bib14","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.7326\/0003-4819-128-12_Part_1-199806150-00007","article-title":"Factor V Leiden mutation as a risk factor for recurrent pregnancy loss","volume":"128","author":"Ridker","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.trsl.2008.11.003_bib15","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1055\/s-0037-1613894","article-title":"Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin","volume":"83","author":"Brenner","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.trsl.2008.11.003_bib16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/107602960000600301","article-title":"Recurrent miscarriage syndrome due to blood coagulation protein\/platelet defects: prevalence, treatment and outcome results. DRW Metroplex Recurrent Miscarriage Syndrome Cooperative Group","volume":"6","author":"Bick","year":"2000","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.trsl.2008.11.003_bib17","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1521-6934(03)00006-3","article-title":"Inherited thrombophilia and poor pregnancy outcome","volume":"17","author":"Brenner","year":"2003","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.trsl.2008.11.003_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1477-7827-1-111","article-title":"Thrombophilia and pregnancy","volume":"1","author":"Kupferminc","year":"2003","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.trsl.2008.11.003_bib19","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3109\/00016340009169243","article-title":"High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation, abruptio placentae and second trimester loss","volume":"79","author":"Kupferminc","year":"2000","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.trsl.2008.11.003_bib20","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1055\/s-2003-38834","article-title":"Inherited thrombophilia and gestational vascular complications","volume":"29","author":"Kupferminc","year":"2003","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.trsl.2008.11.003_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM199901073400102","article-title":"Increased frequency of genetic thrombophilia in women with complications of pregnancy","volume":"340","author":"Kupferminc","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2008.11.003_bib22","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1046\/j.1471-0528.2002.02194.x","article-title":"Mid-trimester severe intrauterine growth restriction is associated with a high prevalence of thrombophilia","volume":"109","author":"Kupferminc","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/j.trsl.2008.11.003_bib23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0029-7844(00)01094-2","article-title":"Genetic hypofibrinolysis in complicated pregnancies","volume":"97","author":"Glueck","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.trsl.2008.11.003_bib24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1023\/A:1012730325902","article-title":"Thrombophilia and its treatment in pregnancy","volume":"12","author":"Eldor","year":"2001","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.trsl.2008.11.003_bib25","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.fertnstert.2007.03.011","article-title":"Factor V Leiden mutation: a treatable etiology for sporadic and recurrent pregnancy loss","volume":"89","author":"Glueck","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.trsl.2008.11.003_bib26","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0029-7844(02)01938-5","article-title":"Third-trimester unexplained intrauterine fetal death is associated with inherited thrombophilia","volume":"99","author":"Many","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.trsl.2008.11.003_bib27","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0029-7844(01)01621-0","article-title":"Pathologic features of the placenta in women with severe pregnancy complications and thrombophilia","volume":"98","author":"Many","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.trsl.2008.11.003_bib28","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1182\/blood-2003-12-4250","article-title":"Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder","volume":"103","author":"Gris","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2008.11.003_bib29","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1538-7836.2003.00066.x","article-title":"Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia","volume":"1","author":"Carp","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.trsl.2008.11.003_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/10641950109152640","article-title":"Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias","volume":"20","author":"Kupferminc","year":"2001","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.trsl.2008.11.003_bib31","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0140-6736(03)12771-7","article-title":"Thrombophilic disorders and fetal loss: a meta-analysis","volume":"361","author":"Rey","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2008.11.003_bib32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0029-7844(01)01646-5","article-title":"Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials","volume":"99","author":"Empson","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.trsl.2008.11.003_bib33","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1471-0528.2000.tb13240.x","article-title":"The effect of thrombophylaxis on pregnancy outcome in patients with recurrent pregnancy loss associated with factor V Leiden mutation","volume":"107","author":"Younis","year":"2000","journal-title":"BJOG"},{"key":"10.1016\/j.trsl.2008.11.003_bib34","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1055\/s-2000-13733","article-title":"Recurrent pregnancy loss: summary and clinical recommendations","volume":"18","author":"Lee","year":"2000","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.trsl.2008.11.003_bib35","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/S0002-9378(96)70610-5","article-title":"Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone","volume":"174","author":"Kutteh","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.trsl.2008.11.003_bib36","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.314.7076.253","article-title":"Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)","volume":"314","author":"Rai","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.trsl.2008.11.003_bib37","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1055\/s-0037-1613036","article-title":"Enoxaparin sodium improves pregnancy outcome in aspirin-resistant antiphospholipid\/antiprotein antibody syndromes","volume":"87","author":"Gris","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.trsl.2008.11.003_bib38","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1538-7836.2004.01130.x","article-title":"The long and winding road. towards LMWH for pregnancy loss","volume":"3","author":"Gris","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.trsl.2008.11.003_bib39","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/107602960501100206","article-title":"A protocol for the use of enoxaparin during pregnancy: results from 85 pregnancies including 13 multiple gestation pregnancies","volume":"11","author":"Huxtable","year":"2005","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.trsl.2008.11.003_bib40","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1160\/TH05-03-0212","article-title":"Modulation of systemic hemostatic parameters by enoxaparin during gestation in women with thrombophilia and pregnancy loss","volume":"94","author":"Sarig","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.trsl.2008.11.003_bib41","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000091357","article-title":"Inherited thrombophilia: treatment during pregnancy","volume":"21","author":"De Carolis","year":"2006","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.trsl.2008.11.003_bib42","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/MBC.0b013e3282f54545","article-title":"Antithrombotic prophylaxis during pregnancy in women with deficiency of natural anticoagulants","volume":"19","author":"Grandone","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.trsl.2008.11.003_bib43","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0015-0282(00)01614-9","article-title":"Are women with polycystic ovary syndrome resistant to activated protein C?","volume":"74","author":"Atiomo","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.trsl.2008.11.003_bib44","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/humrep\/17.2.314","article-title":"Polycystic ovarian syndrome and thrombophilia","volume":"17","author":"Tsanadis","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.trsl.2008.11.003_bib45","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0020-7292(00)00202-2","article-title":"Low-molecular-weight heparin for thrombophilia in pregnant women","volume":"69","author":"Bar","year":"2000","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.trsl.2008.11.003_bib46","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.fertnstert.2005.03.048","article-title":"Effects of enoxaparin on late pregnancy complications and neonatal outcome in women with recurrent pregnancy loss and thrombophilia: results from the Live-Enox study","volume":"84","author":"Brenner","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.trsl.2008.11.003_bib47","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0015-0282(01)02845-X","article-title":"Preferential X-chromosome inactivation in women with idiopathic recurrent pregnancy loss","volume":"76","author":"Uehara","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.trsl.2008.11.003_bib48","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1067\/mob.2001.117659","article-title":"Immunoglobulin A anti-beta2-glycoprotein antibodies in women who experience unexplained recurrent spontaneous abortion and unexplained fetal death","volume":"185","author":"Lee","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.trsl.2008.11.003_bib49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0165-0378(01)00069-9","article-title":"Cytokine promoter gene polymorphisms and idiopathic recurrent pregnancy loss","volume":"51","author":"Babbage","year":"2001","journal-title":"J\u00a0Reprod Immunol"},{"key":"10.1016\/j.trsl.2008.11.003_bib50","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/humrep\/deh109","volume":"19","author":"Glueck","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.trsl.2008.11.003_bib51","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00003086-200105000-00004","article-title":"Hypofibrinolysis, thrombophilia, osteonecrosis","author":"Glueck","year":"2001","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.trsl.2008.11.003_bib52","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1055\/s-0037-1614564","article-title":"The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and PAI-1 in children and adults","volume":"81","author":"Balasa","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.trsl.2008.11.003_bib53","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0015-0282(01)03202-2","article-title":"Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome","volume":"77","author":"Glueck","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.trsl.2008.11.003_bib54","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.trsl.2008.11.003_bib55","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.2337\/diacare.19.10.1138","article-title":"A prospective analysis of the HOMA model. The Mexico City Diabetes Study","volume":"19","author":"Haffner","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1016\/j.trsl.2008.11.003_bib56","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1053\/meta.2000.6749","article-title":"The 4G\/4G polymorphism of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: an independent risk factor for serious pregnancy complications","volume":"49","author":"Glueck","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/j.trsl.2008.11.003_bib57","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1373\/49.7.1081","article-title":"Plasminogen activator inhibitor 1 4G\/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: impaired fibrinolysis and early pregnancy loss","volume":"49","author":"Dossenbach-Glaninger","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.trsl.2008.11.003_bib58","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1093\/humrep\/deg474","article-title":"Polymorphisms in the ACE and PAI-1 genes are associated with recurrent spontaneous miscarriages","volume":"18","author":"Buchholz","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.trsl.2008.11.003_bib59","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00003086-200105000-00004","article-title":"Hypofibrinolysis, thrombophilia, osteonecrosis","author":"Glueck","year":"2001","journal-title":"Clin Orthop"},{"key":"10.1016\/j.trsl.2008.11.003_bib60","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1001\/jama.288.14.1723","article-title":"Prevalence and trends in obesity among US adults, 1999-2000","volume":"288","author":"Flegal","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.trsl.2008.11.003_bib61","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.metabol.2003.06.001","article-title":"Polycystic ovary syndrome, the G1691A factor V Leiden mutation, and plasminogen activator inhibitor activity: associations with recurrent pregnancy loss","volume":"52","author":"Glueck","year":"2003","journal-title":"Metabolism"},{"key":"10.1016\/j.trsl.2008.11.003_bib62","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/01.AOG.0000137832.86727.e2","article-title":"Recurrent fetal aneuploidy and recurrent miscarriage","volume":"104","author":"Sullivan","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.trsl.2008.11.003_bib63","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.fertnstert.2003.09.059","article-title":"Parental karyotype and subsequent live births in recurrent miscarriage","volume":"81","author":"Carp","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.trsl.2008.11.003_bib64","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00001703-200306000-00010","article-title":"Is miscarriage a coagulopathy?","volume":"15","author":"Rai","year":"2003","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.trsl.2008.11.003_bib65","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0015-0282(99)00360-X","article-title":"Thrombophilia-associated pregnancy wastage","volume":"72","author":"Blumenfeld","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.trsl.2008.11.003_bib66","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/humrep\/17.2.442","article-title":"Factor V Leiden and recurrent miscarriage-prospective outcome of untreated pregnancies","volume":"17","author":"Rai","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.trsl.2008.11.003_bib67","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0002-9378(97)70205-9","article-title":"Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction","volume":"177","author":"Dizon-Townson","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.trsl.2008.11.003_bib68","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.8755-8920.2000.430106.x","article-title":"Activated protein C resistance and factor V Leiden mutation can be associated with first-as well as second-trimester recurrent pregnancy loss","volume":"43","author":"Younis","year":"2000","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.trsl.2008.11.003_bib69","doi-asserted-by":"crossref","first-page":"V175","DOI":"10.1016\/S0049-3848(00)00403-5","article-title":"Low-molecular-weight heparin during pregnancy","volume":"101","author":"Bazzan","year":"2001","journal-title":"Thromb Res"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524408002740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524408002740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T00:44:12Z","timestamp":1557967452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524408002740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S1931524408002740"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2008.11.003","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}